Medpace Inc.

NASDAQ: MEDP · Real-Time Price · USD
461.63
2.97 (0.65%)
At close: Aug 15, 2025, 9:59 AM

Medpace Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.23B 2.16B 2.11B 2.07B 2.03B 1.96B 1.89B 1.78B 1.67B 1.56B 1.46B 1.37B 1.29B 1.21B 1.14B 1.09B 1.03B 955.01M
Cost of Revenue
1.53B 1.48B 1.45B 1.46B 1.45B 1.41B 1.36B 1.28B 1.18B 1.1B 1.03B 969.76M 913.52M 864.95M 814.22M 770.48M 718.22M 662.94M
Gross Profit
705.69M 679.51M 656.3M 614.79M 578.98M 549.46M 524.5M 503.43M 489.27M 463.95M 432.44M 404.69M 372.75M 348.4M 328.15M 323.02M 310.09M 292.07M
Operating Income
477.51M 456.32M 446.87M 408.81M 381.45M 354.69M 336.82M 325.94M 318.86M 300.7M 278.7M 257.12M 233.01M 215.22M 198.62M 198.75M 191.46M 179.14M
Interest Income
22.95M 27.34M 25M 18.96M 11.43M 5.96M 1.84M n/a n/a n/a 54K 54K 54K 54K n/a n/a n/a n/a
Pretax Income
495.37M 481.31M 475.92M 432.75M 397.17M 362.43M 335.68M 318.62M 317.31M 303.57M 282.86M 265.14M 237.98M 218.67M 201.85M 200.63M 192.89M 180.56M
Net Income
418.3M 416.39M 404.39M 365.67M 339.79M 312.51M 282.81M 273.18M 268.66M 256.95M 245.37M 226.73M 209.28M 199.85M 181.85M 182.68M 175.57M 159.74M
Selling & General & Admin
199.21M 194M 180.18M 177.26M 169.46M 167.41M 161.35M 152.24M 146.25M 140.06M 131.4M 125.66M 118.29M 112.05M 108.42M 103.14M 97.89M 92.77M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
28.97M 29.19M 29.25M 28.72M 28.08M 27.36M 26.33M 25.25M 24.17M 23.19M 22.34M 21.91M 21.45M 21.14M 21.12M 21.14M 20.74M 20.17M
Operating Expenses
228.18M 223.19M 209.44M 205.98M 197.53M 194.77M 187.68M 177.49M 170.42M 163.25M 153.74M 147.57M 139.74M 133.19M 129.54M 124.28M 118.63M 112.94M
Interest Expense
n/a n/a n/a n/a 105K 1.47M 1.47M 1.47M 2.95M 2.13M 2.13M 2.13M 589K 68K 68K 68K 27K n/a
Selling & Marketing Expenses
1.5M 1.5M 1.5M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.75B 1.7B 1.66B 1.66B 1.65B 1.61B 1.55B 1.46B 1.35B 1.26B 1.18B 1.12B 1.05B 998.14M 943.76M 894.75M 836.85M 775.87M
Income Tax Expense
77.07M 64.92M 71.54M 67.08M 57.38M 49.93M 52.87M 45.44M 48.65M 46.62M 37.49M 38.4M 28.7M 18.81M 20M 17.95M 17.32M 20.83M
Shares Outstanding (Basic)
29.49M 30.39M 30.95M 31.05M 30.99M 30.84M 30.72M 30.63M 30.54M 31.01M 31.19M 31.01M 32.49M 34.92M 35.98M 31.01M 35.89M 35.75M
Shares Outstanding (Diluted)
30.16M 31.2M 32.01M 32.09M 32.09M 32M 31.82M 31.76M 31.57M 32.16M 32.42M 32.25M 33.7M 36.36M 37.74M 32.25M 37.71M 37.75M
EPS (Basic)
13.82 13.51 13.06 11.83 11.02 10.17 9.20 8.85 8.68 8.20 7.60 6.79 6.01 5.60 5.06 5.09 4.90 4.47
EPS (Diluted)
13.45 13.10 12.63 11.42 10.63 9.81 8.88 8.53 8.36 7.89 7.31 6.52 5.76 5.36 4.81 4.83 4.63 4.21
EBITDA
490.74M 485.51M 476.12M 439.73M 411.72M 384.25M 365.35M 342.16M 339.64M 322.82M 299.97M 286.99M 257.83M 237.69M 221.06M 221.21M 212.47M 199.31M
EBIT
475.71M 456.32M 446.87M 411.01M 383.64M 356.89M 339.02M 316.91M 315.48M 299.63M 277.63M 265.08M 236.38M 216.55M 199.94M 200.08M 191.72M 179.14M
Depreciation & Amortization
15.02M 29.19M 29.25M 28.72M 28.08M 27.36M 26.33M 25.25M 24.17M 23.19M 22.34M 21.91M 21.45M 21.14M 21.12M 21.14M 20.74M 20.17M